PET with 64Cu-histidine for noninvasive diagnosis of biliary copper excretion in long-Evans cinnamon rat model of Wilson disease

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 961-968

  Bahde, Ralf ^a   Kapoor, Sorabh ^a   Bhargava, Kuldeep K ^b,c   Schilsky, Michael L ^d   Palestro, Christopher J ^b,c   Gupta, Sanjeev ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Northwell Health   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atb7b; Positron emission tomography; Radiocopper; Wilson disease

Indexed keywords

COPPER; HISTIDINE CU 64; TRACER; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN; DIAGNOSTIC AGENT; HISTIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG RETENTION; DRUG UPTAKE; HEPATOCYTE TRANSPLANTATION; LIVER CLEARANCE; LIVER INJURY; LIVER LEVEL; NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; THERAPY EFFECT; WILSON DISEASE; ANIMAL; BILE; DISEASE MODEL; FISCHER 344 RAT; LIVER CELL; LIVER DISEASE; LONG EVANS CINNAMON RAT; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; TRANSPLANTATION;

ANIMALS; BILE; COPPER; COPPER RADIOISOTOPES; DISEASE MODELS, ANIMAL; HEPATOCYTES; HEPATOLENTICULAR DEGENERATION; HISTIDINE; LIVER DISEASES; METABOLIC CLEARANCE RATE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, INBRED F344; RATS, INBRED LEC;

EID: 84861912162     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.092361     Document Type: Article

References (34)

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet. 2007;369:397-408. (Pubitemid 46177228)
2. Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol. 2008;4:176-185. (Pubitemid 351264130)
3. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5:327-337. (Pubitemid 23351302)
4. Irani AN, Malhi H, Slehria S, et al. Correction of liver disease following transplantation of normal hepatocytes in LEC rats modeling Wilson's disease. Mol Ther. 2001;3:302-309. (Pubitemid 32514645)
5. Malhi H, Joseph B, Schilsky ML, Gupta S. Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease. Regen Med. 2008;3:165-173. (Pubitemid 351546457)
6. Joseph B, Kapoor S, Schilsky ML, Gupta S. Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology. 2009;49:1616-1624.
7. Ha-Hao D, Merle U, Hofmann C, et al. Chances and shortcomins of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats. Z Gastroenterol. 2002;40:209-216. (Pubitemid 34532652)
8. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology. 1979;77:138-142. (Pubitemid 9211613)
9. 64) in the rat. Am J Physiol. 1965;209:900-904.
10. Dunn MA, Green MH, Leach RM Jr. Kinetics of copper metabolism in rats: a compartmental model. Am J Physiol. 1991;261:E115-E125.
11. Gibbs K, Hanka R, Walshe JM. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management. Q J Med. 1978;47:349-364. (Pubitemid 9006413)
12. Schilsky ML, Irani AN, Gorla GR, Volenberg I, Gupta S. Biliary copper excretion capacity in intact animals: correlation between ATP7B gene function, hepatic mass and copper excretion. J Biochem Mol Toxicol. 2000;14:210-214.
13. Deschamps P, Kulkarni PP, Gautam-Basak M, Sarkar B. The saga of copper(II)-L-histidine. Coord Chem Rev. 2005;249:895-909. (Pubitemid 40460938)
14. Wernimont AK, Huffman DL, Lamb AL, O'Halloran TV, Rosenzweig AC. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins. Nat Struct Biol. 2000;7:766-771.
15. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 1994;7:541-545. (Pubitemid 24308344)
16. Ahmed S, Deng J, Borjigin J. A new strain of rat for functional analysis for PINA. Brain Res Mol Brain Res. 2005;137:63-69. (Pubitemid 40798887)
17. Yoshida Y, Tokusashi Y, Lee GH, Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans Cinnamon Rats. Gastroenterology. 1996;111:1654-1660. (Pubitemid 26404231)
18. Joseph B, Bhargava KK, Trunco G, Kumaran V, Palestro CJ, Gupta S. Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation. J Nucl Med. 2005;46:146-152. (Pubitemid 43086009)
19. Joseph B, Bhargava KK, Tronco GG, Palestro CJ, Gupta S. Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin. Nucl Med Commun. 2008;29:336-344. (Pubitemid 351644381)
20. 99mTc-mebrofenin into bile and offers molecular pathway-specific liver imaging. J Nucl Med. 2009;50:1140-1146.
21. Kuzuya T, Amioka K, Nabeshima T. Valproic acid increases biliary copper excretion in the rat. Epilepsy Res. 2002;51:279-285. (Pubitemid 35232573)
22. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab. 2003;88: 277-284. (Pubitemid 36115178)
23. Sanokawa-Akakura R, Dai H, Akakura S. Weinstein, Fajardo JE, Lang SE, Wadsworth S, Siekierka J, Birge RB. A novel role for the immunophilin FKBP52 in copper transport. J Biol Chem. 2004;279:27845-27848.
24. Krohn N, Kapoor S, Enami Y, et al. Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells. Gastroenterology. 2009;136:1806-1817.
25. Benten D, Kumaran V, Joseph B, et al. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in rats. Hepatology. 2005;42:1072-1081. (Pubitemid 43112674)
26. Hung IH, Suzuki M, Yamaguchi Y, Yuan DS, Klausner RD, Gitlin JD. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem. 1997;272: 21461-21466. (Pubitemid 27374018)
27. Bingham MJ, McArdle HJ. A comparison of copper uptake by liver plasma membrane vesicles and uptake by isolated cultured rat hepatocytes. Hepatology. 1994;20:1024-1031. (Pubitemid 24296513)
28. McArdle HJ, Guthrie JR, Ackland ML, Danks DM. Albumin has no role in the uptake of copper by human fibroblasts. J Inorg Biochem. 1987;31:123-131.
29. Basosi R, Valensin G, Gaggelli E, et al. Multifrequency ESR of Cu(II)-(His), (His = Histidine). 1. Immobile Phase. Inorg Chem. 1986;25:3006-3010.
30. Venelinov T, Arpadjan S, Karadjova I, Beattie J. Properties of the copper(II)-histidine complex obtained after dialysis of human plasma with histidine. Acta Pharm. 2006;56:105-112. (Pubitemid 43253978)
31. Deschamps P, Kulkarni PP, Sarkar B. X-ray structure of physiological copper (II) - bis(l-histidinato) complex. Inorg Chem. 2004;43:3338-3340.
32. Vasconcelos MTSD, Almeida CMR. Electrochemical study of proton ionisation, copper(II) complexation and surfactant properties of piperazine-N-N′-bis[2-hydroxypropanesulfonic acid] pH buffer: comparison with other N-substituted aminosulfonic acids pH buffers. Anal Chim Acta. 1998;369:115-122. (Pubitemid 28287302)
33. Bissig KD, Honer M, Zimmermann K, Summer KH, Solioz M. Whole animal copper flux assessed by positron emission tomography in the Long-Evans cinnamon rat: a feasibility study. Biometals. 2005;18:83-88. (Pubitemid 40576080)
34. Peng F, Lutsenko S, Sun X, Muzik O. Positron emission tomography of copper metabolism in the Atp7b (-/-) knock-out mouse model of Wilson's disease. Mol Imaging Biol. 2012;14:70-78.